Literature DB >> 7680389

Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.

S M Dilworth1, V P Horner.   

Abstract

Fourteen pGEX plasmids that express defined regions of polyomavirus middle T antigen in bacteria have been constructed. These polypeptides have been used to generate 18 new monoclonal antibodies directed against the unique portion of middle T and to map the approximate position of the antibody recognition sites onto the protein sequence. All of the antibodies effectively immunoprecipitate middle T and the associated 60- and 35-kDa components of protein phosphatase 2A. Four of the antibodies, however, do not react with middle T when it is bound to pp60c-src. These four probably bind to amino acids 203 to 218 of the middle T protein sequence, which are encoded by the mRNA immediately 3' to the splice junction that creates the C-terminal unique region. This suggests that additional middle T sequences are required for middle T's interaction with pp60c-src than are needed for its binding to protein phosphatase 2A. The antibodies localize this extra region and provide a means of distinguishing between these two associations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680389      PMCID: PMC240352     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Cellular proteins that associate with the middle and small T antigens of polyomavirus.

Authors:  D C Pallas; V Cherington; W Morgan; J DeAnda; D Kaplan; B Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro.

Authors:  B Schaffhausen; T L Benjamin
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

4.  Monoclonal antibodies against polyoma virus tumor antigens.

Authors:  S M Dilworth; B E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation.

Authors:  G G Carmichael; B S Schaffhausen; D I Dorsky; D B Oliver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  The roles of individual polyoma virus early proteins in oncogenic transformation.

Authors:  M Rassoulzadegan; A Cowie; A Carr; N Glaichenhaus; R Kamen; F Cuzin
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

7.  Uniform nomenclature for monoclonal antibodies directed against virus-coded proteins of simian virus 40 and polyoma virus.

Authors:  L Crawford; E Harlow
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

8.  Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

9.  Polyoma virus transforming protein associates with the product of the c-src cellular gene.

Authors:  S A Courtneidge; A E Smith
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  15 in total

1.  RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes.

Authors:  Evangelos Kiskinis; Magnus Hallberg; Mark Christian; Martina Olofsson; Stephen M Dilworth; Roger White; Malcolm G Parker
Journal:  EMBO J       Date:  2007-11-01       Impact factor: 11.598

2.  Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.

Authors:  N M Dunant; M Senften; K Ballmer-Hofer
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.

Authors:  C E Brewster; H R Glover; S M Dilworth
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  The N terminus of hamster polyomavirus middle T antigen carries a determinant for specific activation of p59c-Fyn.

Authors:  L Goutebroze; N M Dunant; K Ballmer-Hofer; J Feunteun
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Multimerization of polyomavirus middle-T antigen.

Authors:  M Senften; S Dilworth; K Ballmer-Hofer
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Cytoplasmic death signal triggered by SRC-mediated phosphorylation of the adenovirus E4orf4 protein.

Authors:  Marie-Claude Gingras; Claudia Champagne; Mélanie Roy; Josée N Lavoie
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication.

Authors:  L Chen; M M Fluck
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Functional interaction between the SH2 domain of Fyn and tyrosine 324 of hamster polyomavirus middle-T antigen.

Authors:  N M Dunant; A S Messerschmitt; K Ballmer-Hofer
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

Authors:  Rebecca S Muraoka; Nancy Dumont; Christoph A Ritter; Teresa C Dugger; Dana M Brantley; Jin Chen; Evangeline Easterly; L Renee Roebuck; Sarah Ryan; Philip J Gotwals; Victor Koteliansky; Carlos L Arteaga
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.

Authors:  K S Campbell; E Ogris; B Burke; W Su; K R Auger; B J Druker; B S Schaffhausen; T M Roberts; D C Pallas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.